×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CORT – corcept therapeutics incorporated (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CORT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/20
08:46 am
cort
CORT FINAL DEADLINE ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure
Low
Report
CORT FINAL DEADLINE ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure
4/20
12:44 am
cort
Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT
Low
Report
Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT
4/18
08:21 pm
cort
CORT 3-DAY DEADLINE ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure
Low
Report
CORT 3-DAY DEADLINE ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Approaching April 21st Lead Plaintiff Deadline in Securities Fraud Class Action Over Relacorilant Failure
4/18
09:37 am
cort
CORT DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT
Low
Report
CORT DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT
4/17
06:11 pm
cort
Corcept 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
Low
Report
Corcept 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
4/17
12:00 pm
cort
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm
Low
Report
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm
4/17
08:59 am
cort
CORT SHAREHOLDER ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
Low
Report
CORT SHAREHOLDER ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
4/16
07:09 pm
cort
Corcept Deadline: CORT Investors with Losses in Excess of $100K Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
Medium
Report
Corcept Deadline: CORT Investors with Losses in Excess of $100K Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
Date
Time
Symbol
Company Name
Action
%Chg
2/24/2026
04:05 pm
CORT
corcept therapeutics incorporated
MISS
Report
-0.7%
corcept therapeutics incorporated
11/4/2025
04:05 pm
CORT
corcept therapeutics incorporated
MISS
Report
7.8%
corcept therapeutics incorporated
7/31/2025
04:05 pm
CORT
corcept therapeutics incorporated
BEAT
Report
2.7%
corcept therapeutics incorporated
5/5/2025
04:05 pm
CORT
corcept therapeutics incorporated
IN-LINE
Report
-1.8%
corcept therapeutics incorporated
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/17
04:08 pm
cort
Form DEF 14A CORCEPT THERAPEUTICS For: Apr 17
Low
Report
Form DEF 14A CORCEPT THERAPEUTICS For: Apr 17
4/8
07:35 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Apr 07 Filed by: Guyer William
Low
Report
Form 4 CORCEPT THERAPEUTICS For: Apr 07 Filed by: Guyer William
4/8
07:30 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Apr 06 Filed by: WILSON JAMES N
Low
Report
Form 4 CORCEPT THERAPEUTICS For: Apr 06 Filed by: WILSON JAMES N
4/7
12:08 pm
cort
Form 144 CORCEPT THERAPEUTICS Filed by: Guyer William
Low
Report
Form 144 CORCEPT THERAPEUTICS Filed by: Guyer William
3/27
04:28 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Mar 25 Filed by: BELANOFF JOSEPH K
Low
Report
Form 4 CORCEPT THERAPEUTICS For: Mar 25 Filed by: BELANOFF JOSEPH K
3/26
05:43 pm
cort
Form SCHEDULE 13G/A CORCEPT THERAPEUTICS Filed by: VANGUARD GROUP INC
Medium
Report
Form SCHEDULE 13G/A CORCEPT THERAPEUTICS Filed by: VANGUARD GROUP INC
3/25
03:49 pm
cort
Form 144 CORCEPT THERAPEUTICS Filed by: BELANOFF JOSEPH K
Low
Report
Form 144 CORCEPT THERAPEUTICS Filed by: BELANOFF JOSEPH K
3/25
01:32 pm
cort
Form 8-K CORCEPT THERAPEUTICS For: Mar 25
Low
Report
Form 8-K CORCEPT THERAPEUTICS For: Mar 25
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/1
Q2/2019 6/30/2019 EPS 0.250 ZacksConsensus 0.180 ActVsEst 0.070 - Beat
14.1%
11/8 Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 9.1%
4/17 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.4%
2/28 Form 4 CORCEPT THERAPEUTICS For: Feb 26 Filed by: BELANOFF JOSEPH K 4.8%
3/13 Form 8-K CORCEPT THERAPEUTICS For: Mar 12 3.1%
9/24 Corcept Therapeutics Incorporated (NASDAQ: CORT) is now covered by analysts at Jefferies Financial Group Inc. They set a "buy" rating on the stock. 3.0%
5/14 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at TheStreet from a "b" rating to a "c+" rating. 2.9%
11/7 Q3/2019 9/30/2019 EPS 0.310 ZacksConsensus 0.190 ActVsEst 0.120 - Beat 2.8%
5/23 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 2.7%
4/2 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 2.7%
11/8 Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 9.1%
4/17 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.4%
2/28 Form 4 CORCEPT THERAPEUTICS For: Feb 26 Filed by: BELANOFF JOSEPH K 4.8%
3/13 Form 8-K CORCEPT THERAPEUTICS For: Mar 12 3.1%
9/24 Corcept Therapeutics Incorporated (NASDAQ: CORT) is now covered by analysts at Jefferies Financial Group Inc. They set a "buy" rating on the stock. 3.0%
5/14 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at TheStreet from a "b" rating to a "c+" rating. 2.9%
11/7 Q3/2019 9/30/2019 EPS 0.310 ZacksConsensus 0.190 ActVsEst 0.120 - Beat 2.8%
5/23 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 2.7%
4/2 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 2.7%
TOP News Decliners
3/5
Form 5 CORCEPT THERAPEUTICS For: Dec 31 Filed by: BAKER G LEONARD JR
-6.8%
3/13 Form 3 CORCEPT THERAPEUTICS For: Mar 12 Filed by: Alton Gregg H -6.4%
11/7 Corcept Therapeutics Incorporated (CORT) Q3 2019 Earnings Call Transcript [The Motley Fool] -5.4%
2/28 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.1%
5/9 Q1/2019 3/31/2019 EPS 0.200 ZacksConsensus 0.180 ActVsEst 0.020 - Beat -5.1%
1/30 Form 8-K CORCEPT THERAPEUTICS For: Jan 30 -4.6%
3/12 Corcept Therapeutics Appoints Gregg Alton to Board of Directors -4.4%
8/20 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at TheStreet from a "c+" rating to a "b" rating. -3.9%
4/27 Form DEF 14A CORCEPT THERAPEUTICS For: Apr 27 -3.5%
6/5 Form 4 CORCEPT THERAPEUTICS For: Jun 03 Filed by: BAKER G LEONARD JR -2.7%
3/13 Form 3 CORCEPT THERAPEUTICS For: Mar 12 Filed by: Alton Gregg H -6.4%
11/7 Corcept Therapeutics Incorporated (CORT) Q3 2019 Earnings Call Transcript [The Motley Fool] -5.4%
2/28 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.1%
5/9 Q1/2019 3/31/2019 EPS 0.200 ZacksConsensus 0.180 ActVsEst 0.020 - Beat -5.1%
1/30 Form 8-K CORCEPT THERAPEUTICS For: Jan 30 -4.6%
3/12 Corcept Therapeutics Appoints Gregg Alton to Board of Directors -4.4%
8/20 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at TheStreet from a "c+" rating to a "b" rating. -3.9%
4/27 Form DEF 14A CORCEPT THERAPEUTICS For: Apr 27 -3.5%
6/5 Form 4 CORCEPT THERAPEUTICS For: Jun 03 Filed by: BAKER G LEONARD JR -2.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: